Fred D. Lublin, MD, FAAN, FANAPresented by:
Fred D. Lublin, MD, FAAN, FANA
Mount Sinai School of Medicine

Patricia K. Coyle, MD
Stony Brook University


CME/CE Information

Activity Title Understanding Progressive MS and New Treatment Developments
Topic Multiple Sclerosis
Accreditation Type AMA PRA Category 1 Credit™/ANCC Contact Hours
Release Date January 31, 2016
Expiration Date January 30, 2017 – No longer available for credit
Estimated Time to Complete Activity 45 minutes


Upon completion of the activity, participants should be able to:

  • Discuss key patient, disease, and drug characteristics that factor into initial and follow-up treatment selection
  • Delineate common questions/concerns voiced by patients regarding DMTs and identify resources that can help with patient education


Fred D. Lublin, MD, FAAN, FANA
Saunders Family Professor of Neurology
Director, The Corinne Goldsmith Dickinson Center for Multiple Sclerosis
Mount Sinai School of Medicine
New York, New York

Patricia K. Coyle, MD
Professor of Neurology and Vice Chair of Clinical Affairs
Director, MS Comprehensive Care Center
Stony Brook University
Stony Brook, New York


  1. There are no fees for participating in and receiving credit for this activity.
  2. Review the activity objectives and CME/CE information.
  3. Complete the CME/CE activity.
  4. Complete the posttest. A score of at least 75% is required to successfully complete this activity. The participant may take the test until successfully passed.
  5. Complete the CME/CE evaluation/attestation form, which provides each participant with the opportunity to comment on how participating in the activity will affect their professional practice, the perception of commercial bias, and whether or not the objectives were met.
  6. Your CME/CE certificate will be available for download



This activity is provided by The France Foundation for physician credit. This activity is co-provided by Medical Education Resources (MER) for nursing contact hours.


This activity is intended for neurologists, nurse practitioners, physician assistants and nurses.


Many neurologists are lacking knowledge in recent developments in DMTs and also need to review safety and efficacy data.


The France Foundation is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.


The France Foundation designates this enduring activity for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Medical Education Resources, Inc., is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. Medical Education Resources, Inc., designates 0.75 contact hour(s) of continuing nursing education for RNs and APRNs.


In accordance with the ACCME Standards for Commercial Support, The France Foundation (TFF) and Medical Education Resources, Inc. (MER) require that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. TFF and MER resolve all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs. Furthermore, TFF and MER seek to verify that all scientific research referred to, reported, or used in a CME/CE activity conforms to the generally accepted standards of experimental design, data collection, and analysis. TFF and MER are committed to providing learners with high-quality CME/CE activities that promote improvements in health care and not those of a commercial interest.

Activity Staff Disclosures

The planners, reviewers, editors, staff, CME committee, or other members at The France Foundation who control content have no relevant financial relationships to disclose.

The planners, reviewers, editors, staff, CME committee, or other members at Medical Education Resources, Inc. who control content have no relevant financial relationships to disclose.

Faculty Disclosure

The following faculty report that they have relevant financial relationships to disclose:

  • Patricia K. Coyle, MD has received grants/research support from Actelion, Novartis, and Opexa. She has served as a consultant to AbbVie, Accordant, Acorda, Bayer, Biogen, Genentech/Roche, Genzyme/Sanofi, Novartis, Serono, and Teva.
  • Fred D. Lublin, MD, FAAN, FANA has received grants/research support from Biogen Idec, Celgene, Genzyme, NIH, NMSS, Novartis, Sanofi, Teva, and Transparency Life Sciences. He has served as a consultant to Amgen, AbbVie, Acorda, Actelion, Akros, Bayer Healthcare Pharmaceuticals, BBB Technologies, Biogen Idec, Celgene, EMD Serono, Inc, Forward Pharma, Medlmmune, Novartis, Questcor/Mallinckrodt, Receptos, Roche/Genentech, Osmotica, Sanofi/Genzyme, Teva, TG Therapeutics, Toyama, and XenoPort. Dr. Lublin is co-chief editor for Multiple Sclerosis and Related Disorders and has stock ownership in Cognition Pharmaceuticals, Inc.


TFF and MER require CME faculty (speakers) to disclose when products or procedures being discussed are off label, unlabeled, experimental, and/or investigational, and any limitations on the information that is presented, such as data that are preliminary, or that represent ongoing research, interim analyses, and/or unsupported opinion. Faculty in this activity may discuss information about pharmaceutical agents that is outside of US Food and Drug Administration approved labeling. This information is intended solely for continuing medical education and is not intended to promote off-label use of these medications. TFF and MER do not recommend the use of any agent outside of the labeled indications. If you have questions, contact the Medical Affairs Department of the manufacturer for the most recent prescribing information.


This activity is supported by an educational grant from Genzyme, a Sanofi company, and Genentech.


The France Foundation and Medical Education Resources, Inc. present this information for educational purposes only. The content is provided solely by faculty who have been selected because of recognized expertise in their field. Participants have the professional responsibility to ensure that products are prescribed and used appropriately on the basis of their own clinical judgment and accepted standards of care. The France Foundation and Medical Education Resources, Inc. assume no liability for the information herein.


Copyright © 2016 The France Foundation. Any unauthorized use of any materials on the site may violate copyright, trademark, and other laws. You may view, copy, and download information or software ("Materials") found on the Site subject to the following terms, conditions, and exceptions:

  • The materials are to be used solely for personal, noncommercial, informational and educational purposes. The materials are not to be modified. They are to be distributed in the format provided with the source clearly identified. The copyright information or other proprietary notices may not be removed, changed, or altered.
  • Materials may not be published, uploaded, posted, transmitted (other than as set forth herein), without The France Foundation's prior written permission.


The France Foundation protects the privacy of personal and other information regarding participants and educational collaborators. The France Foundation will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting purposes to the ACCME.

The France Foundation maintains physical, electronic, and procedural safeguards that comply with federal regulations to protect against the loss, misuse or alteration of information that we have collected from you.

Additional information regarding The France Foundation’s Privacy Policy can be viewed at


If you have questions about this CME/CNE activity, please contact The France Foundation at 860-434-1650 or This email address is being protected from spambots. You need JavaScript enabled to view it. or Medical Education Resources, Inc. at This email address is being protected from spambots. You need JavaScript enabled to view it.



Latest CME/CNE Education

  • Advances in MS Assessment: Biomarkers and Imaging

    Read More
  • Defining the Clinical Course of Multiple Sclerosis

    Read More
  • Partners in Care: Engaging Patients With Shared Decision-Making Strategies and the Comprehensive Care Team

    Read More